COVID-19 clinical trial disruption declines but trials continue to suffer from slow recruitment Read more
Moderna publishes interim results from older adults in phase 1 study of its COVID-19 vaccine Read more
Bispecific antibodies will mature after 2021, $6bn estimated sales in oncology by 2025: GlobalData Read more